2 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of the Japanese Encephalitis virus vaccine from China
Issued September 7, 2011 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN1 N180735 (September 7, 2011)
Tariff classification
HTS codes: 3002.20.0000
Headings: 3002
Product description
The subject merchandise is a single frozen aliquot of the Japanese Encephalitis Vaccine SA 14-14-2 vaccine virus which contains live attenuated Japanese encephalitis virus, buffer salts, sugars and human serum albumin with a dilute of sterile water for injection presented in a vial. The material is indicated for research & development and will be used solely for in-vitro analysis.
CBP rationale
The applicable subheading for Japanese Encephalitis Vaccine the will be 3002.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine”.
Full text
N180735 September 7, 2011 CLA-2-30:OT:RR:E:NC:N2:N238 CATEGORY: Classification TARIFF NO.: 3002.20.0000 Ms. Paula Swanson Sanofi Pasteur, Inc. Discovery Drive Swiftwater, PA 18370 RE: The tariff classification of the Japanese Encephalitis virus vaccine from China Dear Ms. Swanson: In your letter dated August 16, 2011, you requested a tariff classification ruling. The subject merchandise is a single frozen aliquot of the Japanese Encephalitis Vaccine SA 14-14-2 vaccine virus which contains live attenuated Japanese encephalitis virus, buffer salts, sugars and human serum albumin with a dilute of sterile water for injection presented in a vial. The material is indicated for research & development and will be used solely for in-vitro analysis. The applicable subheading for Japanese Encephalitis Vaccine the will be 3002.20.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Vaccines for human medicine”. The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact the National Import Specialist at (646) 733-3033. Sincerely, Robert B. Swierupski Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Freeze Dried BCG Vaccine and Freeze Dried Tuberculin, Purified Protein Derivative (PPD) from Japan
The tariff classification of Finished Vaccine Concentrates from France
The tariff classification of Recombinant Yellow Fever virus vaccine from France
The tariff classification of Menactra Vaccine from the United Kingdom
The tariff classification, country of origin marking, and status under the United States-Australia Free Trade Agreement (UAFTA), of Influenza Virus Vaccine from Australia.
The tariff classification of Fluzone® High-Dose Influenza Virus Vaccine of United States origin put up in dosage form in France
The tariff classification of an investigational vaccine from France
The tariff classification of Engerix-B [Hepatitis B Vaccine (Recombinant)] from Belgium
The tariff classification of Infanrix (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) from Belgium
The tariff classification of Havrix (Hepatitis A Vaccine, Inactivated) from Belgium
Follow N180735
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.